Alan Nevill

ORCID: 0000-0003-0506-3652 · 1 paper in corpus
rct 1984
The Lancet ·doi:10.1016/s0140-6736(84)91872-5

222 patients with disseminated breast cancer have been randomised to receive either a combination of hormone therapies using tamoxifen, aminoglutethimide with hydrocortisone, and danazol (TAD), or tamoxifen alone. The response to the combin…